Mylan Revenue and Competitors
Estimated Revenue & Valuation
- Mylan's total funding is $30M.
Employee Data
- Mylan has 16258 Employees.
- Mylan grew their employee count by -2% last year.
Mylan's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP NA National Accounts & Channel Development | Reveal Email/Phone |
2 | Head Global Quality Integration and Surveillance | Reveal Email/Phone |
3 | Head Medical Affairs UK,IE and Malta | Reveal Email/Phone |
4 | head strategic engineering Biologics/Respiratory/Global Key Brands | Reveal Email/Phone |
5 | Director Pricing and Contracts Product Launch Strategy | Reveal Email/Phone |
6 | Director, Global Commercial Development - Biologics & Insulins | Reveal Email/Phone |
7 | Director Commercial Performance and Business Analytics - Office the President | Reveal Email/Phone |
8 | Senior Director, Global Biosimilars Policy | Reveal Email/Phone |
9 | Director, Global Marketing PMO | Reveal Email/Phone |
10 | Director - QA Equipment, Facilities, and Systems at Mylan | Reveal Email/Phone |
Mylan Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $43.2M | 215 | 6% | N/A | N/A |
#2 | $81.8M | 407 | 10% | N/A | N/A |
#3 | $11.7M | 58 | 0% | N/A | N/A |
#4 | $1011.8M | 5034 | -9% | N/A | N/A |
#5 | $44.8M | 223 | 1% | N/A | N/A |
#6 | $13.1M | 65 | 5% | N/A | N/A |
#7 | $16.5M | 82 | 41% | N/A | N/A |
#8 | $17.3M | 86 | -5% | N/A | N/A |
#9 | $67.9M | 338 | 23% | N/A | N/A |
#10 | $14.9M | 74 | 7% | N/A | N/A |
What Is Mylan?
Mylan Laboratories Inc. is a leading pharmaceutical company that develops, manufactures and markets generic and proprietary prescription pharmaceutical products. The Company markets an extensive line of generic products through three business units, Mylan Pharmaceuticals Inc., Mylan Technologies Inc., and UDL Laboratories, Inc. and branded products through its Bertek Pharmaceuticals Inc.
keywords:N/A
$30M
Total Funding
16258
Number of Employees
N/A
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Mylan News
The recall affects batch BF21002800 of Mylan's unbranded insulin glargine-yfgn, a long-acting insulin analog used to improve glycemic control...
Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin...
The next chapter for the former Mylan pharmaceutical manufacturing facility began Thursday, March 31, as a West Virginia University entity...